AVR Revenue Flow
Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
- 2026-06-30: Revenue $1.01M; Cost of revenue $233.00K; Research and development $23.37M; Selling, general and administrative $8.40M.
- 2026-03-31: Revenue $494.00K; Cost of revenue $114.00K; Research and development $17.46M; Selling, general and administrative $6.93M.
- 2025-12-31: Revenue $310.00K*; Cost of revenue $91.00K*; Research and development $19.51M*; Selling, general and administrative $9.67M*.
- 2025-09-30: Revenue $429.00K; Cost of revenue $123.00K; Research and development $16.81M; Selling, general and administrative $5.76M.
Major Customers
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Geography
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Segment
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown
Revenue and expense 3 month
| Period end | Revenue | Cost of revenue | Research and development | Selling, general and administrative | Income tax | Net income |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.01M | $233.00K | $23.37M | $8.40M | $0.00 | -$29.09M |
| 2026-03-31 | $494.00K | $114.00K | $17.46M | $6.93M | $492.00K | -$23.02M |
| 2025-12-31 | $310.00K* | $91.00K* | $19.51M* | $9.67M* | $0.00* | -$29.20M* |
| 2025-09-30 | $429.00K | $123.00K | $16.81M | $5.76M | $0.00 | -$22.24M |
| 2025-06-30 | $618.00K | $148.00K | $16.34M | $5.01M | $0.00 | -$20.83M |
| 2025-03-31 | $556.00K | $207.00K | $16.46M | $5.67M | $0.00 | -$21.86M |
| 2024-09-30 | $769.00K | $443.00K | $13.95M | $6.98M | $0.00 | -$21.86M |
| 2024-06-30 | $632.00K | $312.00K | $12.63M | $6.16M | $0.00 | -$18.71M |
| 2024-03-31 | $766.00K | $473.00K | $11.56M | $6.52M | $0.00 | -$16.35M |
Revenue and expense 6 month
| Period end | Revenue | Cost of revenue | Research and development | Selling, general and administrative | Income tax | Net income |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.50M | $347.00K | $40.83M | $15.33M | $492.00K | -$52.12M |
| 2025-06-30 | $1.17M | $355.00K | $32.80M | $10.69M | $0.00 | -$42.70M |
| 2024-06-30 | $1.40M | $786.00K | $24.19M | $12.68M | $0.00 | -$35.06M |
Revenue and expense 9 month
| Period end | Revenue | Cost of revenue | Research and development | Selling, general and administrative | Income tax | Net income |
|---|---|---|---|---|---|---|
| 2025-09-30 | $1.60M | $478.00K | $49.61M | $16.45M | $0.00 | -$64.94M |
| 2024-09-30 | $2.17M | $1.23M | $38.13M | $19.66M | $0.00 | -$56.91M |
Revenue and expense 12 month
| Period end | Revenue | Revenue including tax | Cost of revenue | Research and development | Selling, general and administrative | Income tax | Net income |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $1.91M | $1.91M | $569.00K | $69.12M | $26.12M | $0.00 | -$94.14M |
| 2024-12-31 | $2.70M | $2.70M | $1.44M | $51.45M | $28.19M | $0.00 | -$76.29M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B |